Development of Levodopa-loaded inhalable dry powders for treatment of Parkinson's disease via the pulmonary system
Parkinson’s Disease (PD) is a progressive disorder characterized by gradual loss of dopaminergic neurons. The deficiency of dopamine in return disrupts the motor & non-motor skills, which significantly reduces the quality of life in the elderly depending upon the stage and severity of the diseas...
Saved in:
Main Author: | Paul, Mahasweta |
---|---|
Other Authors: | Raymond Lau Wai Man |
Format: | Thesis-Doctor of Philosophy |
Language: | English |
Published: |
Nanyang Technological University
2022
|
Subjects: | |
Online Access: | https://hdl.handle.net/10356/158934 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Nanyang Technological University |
Language: | English |
Similar Items
-
Potentials and challenges of Levodopa particle formulation for treatment of Parkinson's disease through intranasal and pulmonary delivery
by: Paul, Mahasweta, et al.
Published: (2022) -
Effect of particle morphology on particle pick-up velocity in dry powder inhaler
by: Chin, Charlotte Shi Shu.
Published: (2009) -
Evaluation of carrier properties for dry powder inhalation applications
by: Nguyen, Thi Quynh Ngoc
Published: (2017) -
Breath tests in diagnosis of pulmonary tuberculosis
by: Cheepsattayakorn,A., et al.
Published: (2015) -
Levodopa and the feedback process on set-shifting in Parkinson's disease
by: Au, Wing Lok, et al.
Published: (2013)